GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LungLife AI Inc (LSE:LLAI) » Definitions » Beneish M-Score

LungLife AI (LSE:LLAI) Beneish M-Score : -2.13 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is LungLife AI Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.13 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for LungLife AI's Beneish M-Score or its related term are showing as below:

LSE:LLAI' s Beneish M-Score Range Over the Past 10 Years
Min: -6.21   Med: -3.26   Max: 6.02
Current: -2.13

During the past 6 years, the highest Beneish M-Score of LungLife AI was 6.02. The lowest was -6.21. And the median was -3.26.


LungLife AI Beneish M-Score Historical Data

The historical data trend for LungLife AI's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LungLife AI Beneish M-Score Chart

LungLife AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - -6.21 6.02 -4.39 -2.13

LungLife AI Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.02 - -4.39 - -2.13

Competitive Comparison of LungLife AI's Beneish M-Score

For the Diagnostics & Research subindustry, LungLife AI's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LungLife AI's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, LungLife AI's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where LungLife AI's Beneish M-Score falls into.



LungLife AI Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of LungLife AI for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.6037+0.528 * 1+0.404 * 1.5773+0.892 * 1.8+0.115 * 0.8461
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.452+4.679 * -0.041212-0.327 * 1.3435
=-2.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was £0.14 Mil.
Revenue was £0.04 Mil.
Gross Profit was £0.04 Mil.
Total Current Assets was £2.61 Mil.
Total Assets was £7.52 Mil.
Property, Plant and Equipment(Net PPE) was £0.31 Mil.
Depreciation, Depletion and Amortization(DDA) was £0.20 Mil.
Selling, General, & Admin. Expense(SGA) was £1.06 Mil.
Total Current Liabilities was £1.14 Mil.
Long-Term Debt & Capital Lease Obligation was £0.09 Mil.
Net Income was £-4.28 Mil.
Gross Profit was £0.00 Mil.
Cash Flow from Operations was £-3.97 Mil.
Total Receivables was £0.13 Mil.
Revenue was £0.02 Mil.
Gross Profit was £0.02 Mil.
Total Current Assets was £7.08 Mil.
Total Assets was £12.33 Mil.
Property, Plant and Equipment(Net PPE) was £0.47 Mil.
Depreciation, Depletion and Amortization(DDA) was £0.23 Mil.
Selling, General, & Admin. Expense(SGA) was £1.30 Mil.
Total Current Liabilities was £1.22 Mil.
Long-Term Debt & Capital Lease Obligation was £0.28 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.138 / 0.036) / (0.127 / 0.02)
=3.833333 / 6.35
=0.6037

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.02 / 0.02) / (0.036 / 0.036)
=1 / 1
=1

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2.609 + 0.307) / 7.522) / (1 - (7.079 + 0.465) / 12.331)
=0.612337 / 0.388209
=1.5773

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.036 / 0.02
=1.8

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.234 / (0.234 + 0.465)) / (0.201 / (0.201 + 0.307))
=0.334764 / 0.395669
=0.8461

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1.056 / 0.036) / (1.298 / 0.02)
=29.333333 / 64.9
=0.452

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.089 + 1.142) / 7.522) / ((0.284 + 1.218) / 12.331)
=0.163653 / 0.121807
=1.3435

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-4.276 - 0 - -3.966) / 7.522
=-0.041212

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

LungLife AI has a M-score of -2.13 suggests that the company is unlikely to be a manipulator.


LungLife AI Beneish M-Score Related Terms

Thank you for viewing the detailed overview of LungLife AI's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


LungLife AI (LSE:LLAI) Business Description

Traded in Other Exchanges
N/A
Address
2545 W. Hillcrest Drive, Suite 140, Thousand Oaks, CA, USA, 91320
LungLife AI Inc is a diagnostic company focused on the early detection of lung cancer from a simple blood draw enhanced by artificial intelligence. Its LungLB Test is a blood-based tool developed to provide clinicians the information needed to make informed decisions about the management of lung nodules and lung cancer.

LungLife AI (LSE:LLAI) Headlines

No Headlines